๐ง ๐๐ฟ๐ฒ๐ฎ๐ธ๐๐ต๐ฟ๐ผ๐๐ด๐ต ๐๐ฟ๐ถ๐ฎ๐น @amsterdamumc.bsky.social ๐ผ๐ณ๐ณ๐ฒ๐ฟ๐ ๐ณ๐ถ๐ฟ๐๐ ๐ต๐ผ๐ฝ๐ฒ ๐ณ๐ผ๐ฟ ๐ฐ๐ต๐ถ๐น๐ฑ๐ฟ๐ฒ๐ป ๐๐ถ๐๐ต ๐ฉ๐ฎ๐ป๐ถ๐๐ต๐ถ๐ป๐ด ๐ช๐ต๐ถ๐๐ฒ ๐ ๐ฎ๐๐๐ฒ๐ฟ ๐ฑ๐ถ๐๐ฒ๐ฎ๐๐ฒ ๐ฌ Van der Knaap: โ๐๐ฉ๐ช๐ด ๐ช๐ด ๐ต๐ฉ๐ฆ ๐ง๐ช๐ณ๐ด๐ต ๐ต๐ช๐ฎ๐ฆ ๐ช๐ต ๐ฉ๐ข๐ด ๐ฃ๐ฆ๐ฆ๐ฏ ๐ด๐ฉ๐ฐ๐ธ๐ฏ ๐ต๐ฉ๐ข๐ต ๐ต๐ฉ๐ช๐ด ๐ง๐ข๐ต๐ข๐ญ ๐ค๐ฉ๐ช๐ญ๐ฅ๐ฉ๐ฐ๐ฐ๐ฅ ๐ฃ๐ณ๐ข๐ช๐ฏ ๐ฅ๐ช๐ด๐ฆ๐ข๐ด๐ฆ ๐ค๐ข๐ฏ ๐ฃ๐ฆ ๐ข๐ฎ๐ฆ๐ญ๐ช๐ฐ๐ณ๐ข๐ต๐ฆ๐ฅ.โ www.amsterdamumc.org/en/research/...
Breakthrough trial offers first hope for children with Vanishing White Matter disease | Amsterdam UMC
A team of researchers from the Amsterdam Leukodystrophy Center at Amsterdam UMC, led by Prof. Marjo van der Knaap, has published the first clinical evidence that the drug guanabenz may alter the cours...
amsterdamumc.org